Please note that SCOTUS Outside Opinions constitute the views of outside contributors and do not reflect the official ...

In the 1930s and 1940s, for example, a group of Polish mathematicians regularly met in a café in Lwów, Poland (now Lviv, ...

A vicious fire inside a violation-plagued Queens building that killed four people — including a toddler — is now being investigated as a homicide, cops said Sunday. The deaths of four people in the ...

The Samsung Galaxy S26 series hit the market a bit earlier this year, and while it hasn’t been out for long, there have been a few issues reported already. Most of the problems have actually been ...

Chelsea are faltering at a key moment in the season and, most concerning of all, there are numerous problems for Liam Rosenior to solve. From issues in goal, indiscipline and conceding from set-pieces ...

Barnet, a global manufacturer, recycler and distributor of high-performance fibres, polymers and yarns since more than 125 years, has just announced that it had signed a partnership with Carbon Fiber ...

Tens of thousands of shoppers are reporting widespread problems using Amazon’s website, according to reports from outage tracker Downdetector. As of 3:45 p.m. ET on Thursday, March 5, reports of ...

Donald Trump’s unorthodox Cabinet spent the last 13-plus months testing the wisdom of a president prioritizing loyalty over experience. That came to a head this week when someone finally got the ax.

A new study finds that certain patterns of AI use are driving cognitive fatigue, while others can help reduce burnout. by Julie Bedard, Matthew Kropp, Megan Hsu, Olivia T. Karaman, Jason Hawes and ...

Abstract: In this work, a novel finite element formulation for the numerical solution of three-dimensional magnetostatic problems is presented. The formulation is derived from the classical vector ...

Prognostic value and clinical utility of a six-gene signature for aggressive prostate cancer among clinically low or intermediate risk patients. This is an ASCO Meeting Abstract from the 2026 ASCO ...

A phase 1/2, open-label, randomized, dose-finding and dose expansion study of gedatolisib in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO ...